markdown
Contents
The Intersection of Politics, Policy, and Innovation
Tim Hwang is a name that resonates with the evolving landscape of politics, policy, and technology startups. From working on Barack Obama’s 2008 presidential campaign to studying public policy at Princeton, Hwang’s trajectory has been remarkable. Before turning 30, he successfully took his first company, FiscalNote, public. Now, he leads Nitra, a revolutionary platform in healthcare finance and operations. Hwang describes it as the culmination of everything he’s pursued.
Nitra: Revolutionising Healthcare Operations
Nitra is a state-of-the-art AI-native platform designed for medical practices. Unlike the piecemeal solutions of billing, purchasing, scheduling, and insurance verification, Nitra offers a unified system. AI agents power this platform, simplifying administrative tasks like expense management and patient communications. As Hwang explains, it’s intended to replace the hodgepodge of software that most practices rely on to stay afloat.
It’s a field ripe for transformation. Healthcare’s administrative layer is notorious for consuming vast time and resources. Nitra automates these back-office tasks, creating a streamlined, efficient process.
Nitra’s Financial Milestones
Recently, Nitra announced a $50 million Series B funding round. This brings their total raised capital to a whopping $205 million. Alongside this, the platform has surpassed $1 billion in annualized processing volume. As of December 2025, it boasts $33 million in annual recurring revenue, an impressive eight-fold growth year-over-year. Over 700 clinics now utilise the platform.
Hwang sees this as just the beginning. “I honestly believe we can get to a billion dollars in revenue in the next couple of years,” he confidently stated to Fortune.
The Ingenious Trojan Horse: A Credit Card
Nitra’s unique entry point for practices is through a well-crafted strategy — a physician-specific credit card. This clever approach links to a backend suite for expense management and more. Hwang aptly calls it a “Trojan horse.” Doctors begin with purchasing medical supplies via the card. The platform then categorises accounting, facilitating a seamless transition into adopting Nitra’s full offerings.
Once onboard, doctors can access Nitra Rx and Nitra Mart. They can purchase pharmaceuticals and specialty equipment directly through the platform. AI agents manage the rest, from account reconciliation to scheduling.
Dr. Richard Park Joins the Journey
To strengthen their position, Nitra welcomes Dr. Richard Park to its board of directors. Park, founder of CityMD and a former Summit Health+CityMD executive, is seen as a legend in healthcare. His presence bridges Nitra to physician entrepreneurs who manage their own practices. “Many founder physicians really look up to Dr. Park,” Hwang noted.
Why Healthcare, Why Now?
Hwang’s fascination with healthcare was cemented during his time with Obama. Observing policymakers struggle with the Affordable Care Act provided insights into the system’s dysfunctions. COVID-19 further highlighted these issues. Watching the crisis unfold, Hwang realised the enormity of the challenge and the opportunity it presented.
Healthcare is now America’s largest employer. For those over 45, it’s often the biggest household expense, surpassing rent and groceries. Hwang is passionate about alleviating these burdens. “If we can unlock 10 to 20% more time for doctors, it would be a tremendous societal impact.”
Transformative Forces in the Industry
Nitra’s rapid growth can be attributed to two main factors. Firstly, supply chain pressures have complicated cost management for medical supplies. Secondly, a shift in how physicians perceive technology plays a significant role. Doctors are embracing AI tools for clinical tasks, paving the way for software to manage administrative duties.
Nitra’s onboarding process has rapidly accelerated. Hwang projects the platform to scale from $1 billion to $4 billion in annualized processing volume by year’s end.
In conclusion, Hwang envisions Nitra becoming a decacorn. With his track record, it’s a vision that’s hard to dismiss.
